A new consensus guideline offers an expert opinion for a multidisciplinary approach to acromegaly. How much headway have we made? Neurosurgery remains the primary therapy in the majority of ...

Affected populations: Acromegaly is estimated to affect approximately 50 to 70 people out of every million. However, the true ...

LONDON--(BUSINESS WIRE)--Technavio has announced their latest drug pipeline analysis report on acromegaly and gigantism. The report includes a comprehensive research on the pipeline molecules ...

Acromegaly is a condition that most often happens when your pea-sized pituitary gland at the base of your brain (orange) makes too much growth hormone after your body has otherwise already stopped ...

SAN DIEGO — Crinetics Pharmaceuticals announced on Sunday that its experimental drug for acromegaly, a rare and serious hormonal disorder, succeeded in a late-stage trial, bringing the San Diego ...

Crinetics is seeking to change the way acromegaly is treated. Ahead of its hopes for a 2025 U.S. drug launch, the biotech is looking to spread awareness about how to treat the condition.